Stocks and Investing
Stocks and Investing
Thu, January 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tony Butler Initiated (ALLO) at Strong Buy and Held Target at $15 on, Jan 5th, 2023
Tony Butler of EF Hutton, Initiated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $15 on, Jan 5th, 2023.
Tony has made no other calls on ALLO in the last 4 months.
There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 0 agree with Tony's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tony
- Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Held Target at $9 on, Monday, December 12th, 2022
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022
- Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, September 22nd, 2022
Contributing Sources